{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:20:22Z","timestamp":1772050822124,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The objectives of this study were to analyze the difference between the preoperative radiological and postoperative pathological stages of colorectal cancer (CRC) and explore the feasibility of elastic lamina invasion (ELI) as a prognostic marker for patients with stage III colon cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 105 consecutive patients underwent radical surgery (R0 resection) for stage III colon cancer at the Cancer Hospital of China Medical University between January 2015 and December 2017. Clinicopathological features, including radiological stage and elastic lamina staining, were analyzed for prognostic significance in stage III colon cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 105 patients with stage III colon cancer who met the criteria and had complete data available were included. The median follow-up period of survivors was 41 months. During the follow-up period, 33 (31.4%) patients experienced recurrence after radical resection, and the 3-year disease-free survival (DFS) rate was 64.8%. The consistency between preoperative radiological and postoperative pathological staging was poor (\u03ba = 0.232, <jats:italic>P<\/jats:italic> &lt; 0.001). The accuracy of \u2264 T2 stage diagnoses was 97.1% (102\/105), that of T3 stage was 60.9% (64\/105), that of T4a stage was 68.6% (72\/105) and that of T4b stage was 91.4% (96\/105). The DFS rate of T3 ELI (+) patients was significantly lower than that of both T3 ELI (\u2212) patients (<jats:italic>P<\/jats:italic> = 0.000) and pT4a patients (<jats:italic>P<\/jats:italic> = 0.013). The DFS rate of T3 ELI (\u2212) patients was significantly higher than that of pT4b patients (P=0.018). T3 ELI (+) (HR (Hazard ratio), 8.444 [95% CI, 1.736\u201341.067]; <jats:italic>P<\/jats:italic> = 0.008), T4b (HR, 57.727[95% CI, 5.547-600.754]; <jats:italic>P<\/jats:italic> = 0.001), N2 stage (HR, 10.629 [95% CI, 3.858\u201329.286]; <jats:italic>P<\/jats:italic> &lt; 0.001), stage III (HR, 0.136 [95% CI, 0.31\u20130.589]; <jats:italic>P<\/jats:italic> = 0.008) and perineural invasion (PNI) (HR, 8.393 [95% CI, 2.094\u201333.637]; <jats:italic>P<\/jats:italic> = 0.003) were independent risk factors for postoperative recurrence of stage III colon cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The consistency between preoperative radiological and postoperative pathological staging was poor, especially for tumors located in the ascending colon and descending colon. Elastic lamina staining is expected to become a stratified indicator of recurrence risk for patients with stage III colon cancer and a guide for individualized adjuvant chemotherapy, thus improving patient prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02865-y","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T04:12:33Z","timestamp":1670818353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic value of elastic lamina staining in patients with stage III colon cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Feifei","family":"Bi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"2865_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, et al. Cancer Statistics, 2021. CA Cancer J Clin. 2021. https:\/\/doi.org\/10.3322\/caac.21654.","DOI":"10.3322\/caac.21654"},{"key":"2865_CR2","doi-asserted-by":"publisher","unstructured":"Zlobec I, Lugli A. Prognostic and predictive factors in colorectal cancer. J Clin Pathol. 2008. https:\/\/doi.org\/10.1136\/jcp.2007.054858.","DOI":"10.1136\/jcp.2007.054858"},{"key":"2865_CR3","doi-asserted-by":"publisher","unstructured":"Foxtrot Collaborative G. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012. https:\/\/doi.org\/10.1016\/S1470-2045(12)70348-0.","DOI":"10.1016\/S1470-2045(12)70348-0"},{"key":"2865_CR4","doi-asserted-by":"publisher","unstructured":"Malmstrom ML, et al. Staging with computed tomography of patients with colon cancer. Int J Color Dis. 2018. https:\/\/doi.org\/10.1007\/s00384-017-2932-3.","DOI":"10.1007\/s00384-017-2932-3"},{"key":"2865_CR5","doi-asserted-by":"publisher","unstructured":"Smith NJ, et al. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials. Br J Cancer. 2007. https:\/\/doi.org\/10.1038\/sj.bjc.6603646.","DOI":"10.1038\/sj.bjc.6603646"},{"key":"2865_CR6","doi-asserted-by":"publisher","unstructured":"Huh JW, et al. Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer. Ann Oncol. 2012. https:\/\/doi.org\/10.1093\/annonc\/mdr404.","DOI":"10.1093\/annonc\/mdr404"},{"key":"2865_CR7","doi-asserted-by":"publisher","unstructured":"Nerad E, et al. Diagnostic accuracy of CT for local staging of colon cancer: a systematic review and meta-analysis. AJR Am J Roentgenol. 2016. https:\/\/doi.org\/10.2214\/AJR.15.15785.","DOI":"10.2214\/AJR.15.15785"},{"key":"2865_CR8","doi-asserted-by":"publisher","unstructured":"Leufkens AM, et al. Diagnostic accuracy of computed tomography for colon cancer staging: a systematic review. Scand J Gastroenterol. 2011. https:\/\/doi.org\/10.3109\/00365521.2011.574732.","DOI":"10.3109\/00365521.2011.574732"},{"key":"2865_CR9","doi-asserted-by":"publisher","unstructured":"Grin A, et al. Peritoneal elastic lamina invasion: limitations in its use as a prognostic marker in stage II colorectal cancer. Hum Pathol. 2013. https:\/\/doi.org\/10.1016\/j.humpath.2013.07.013.","DOI":"10.1016\/j.humpath.2013.07.013"},{"key":"2865_CR10","doi-asserted-by":"publisher","unstructured":"Travis W, et al. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol. 2008. https:\/\/doi.org\/10.1097\/JTO.0b013e31818e0d9f.","DOI":"10.1097\/JTO.0b013e31818e0d9f"},{"key":"2865_CR11","doi-asserted-by":"publisher","unstructured":"Shinto E, et al. The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis Colon Rectum. 2004. https:\/\/doi.org\/10.1007\/s10350-003-0083-9.","DOI":"10.1007\/s10350-003-0083-9"},{"key":"2865_CR12","doi-asserted-by":"publisher","unstructured":"Kojima M, et al. Elastic laminal invasion in colon cancer: diagnostic utility and histological features. Front Oncol. 2012. https:\/\/doi.org\/10.3389\/fonc.2012.00179.","DOI":"10.3389\/fonc.2012.00179"},{"key":"2865_CR13","doi-asserted-by":"publisher","unstructured":"Kojima M, et al. Peritoneal elastic laminal invasion of colorectal cancer: the diagnostic utility and clinicopathologic relationship. Am J Surg Pathol. 2010. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ecfe98.","DOI":"10.1097\/PAS.0b013e3181ecfe98"},{"key":"2865_CR14","doi-asserted-by":"publisher","unstructured":"Yokota M, et al. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III. Dis Colon Rectum. 2014. https:\/\/doi.org\/10.1097\/DCR.0000000000000124.","DOI":"10.1097\/DCR.0000000000000124"},{"key":"2865_CR15","doi-asserted-by":"publisher","unstructured":"Odate T, et al. Assessment of peritoneal elastic laminal invasion improves survival stratification of pT3 and pT4a colorectal cancer: a meta-analysis. J Clin Pathol. 2019. https:\/\/doi.org\/10.1136\/jclinpath-2019-206056.","DOI":"10.1136\/jclinpath-2019-206056"},{"key":"2865_CR16","doi-asserted-by":"publisher","unstructured":"Nakanishi Y, et al. Reappraisal of serosal invasion in patients with T3 colorectal cancer by elastic stain: clinicopathologic study of 139 surgical cases with special reference to peritoneal elastic lamina invasion. Arch Pathol Lab Med. 2016. https:\/\/doi.org\/10.5858\/arpa.2014-0647-OA.","DOI":"10.5858\/arpa.2014-0647-OA"},{"key":"2865_CR17","doi-asserted-by":"publisher","unstructured":"Smith NJ, et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg. 2008. https:\/\/doi.org\/10.1002\/bjs.5917.","DOI":"10.1002\/bjs.5917"},{"key":"2865_CR18","doi-asserted-by":"publisher","unstructured":"Smith NJ, et al. MRI for detection of extramural vascular invasion in rectal cancer. Am J Roentgenol. 2008. https:\/\/doi.org\/10.2214\/AJR.08.1298.","DOI":"10.2214\/AJR.08.1298"},{"key":"2865_CR19","doi-asserted-by":"publisher","unstructured":"Hari D, et al. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? J Am Coll Surg. 2013. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2013.04.018.","DOI":"10.1016\/j.jamcollsurg.2013.04.018"},{"key":"2865_CR20","doi-asserted-by":"publisher","unstructured":"Kim M, et al. Survival paradox between stage IIB\/C (T4N0) and stage IIIA (T1-2N1) colon cancer. Ann Surg Oncol. 2015. https:\/\/doi.org\/10.1245\/s10434-014-3982-1.","DOI":"10.1245\/s10434-014-3982-1"},{"key":"2865_CR21","doi-asserted-by":"publisher","unstructured":"Chu Q, et al. Positive surgical margins contribute to the survival paradox between patients with stage IIB\/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer. Surgery. 2016. https:\/\/doi.org\/10.1016\/j.surg.2016.05.028.","DOI":"10.1016\/j.surg.2016.05.028"},{"key":"2865_CR22","doi-asserted-by":"publisher","unstructured":"Fernandez L, et al. How Reliable Is CT Scan in Staging Right Colon Cancer? Dis Colon Rectum. 2019. https:\/\/doi.org\/10.1097\/dcr.0000000000001387.","DOI":"10.1097\/dcr.0000000000001387"},{"key":"2865_CR23","doi-asserted-by":"publisher","unstructured":"Hompes D, et al. HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol. 2012. https:\/\/doi.org\/10.1093\/annonc\/mds173.","DOI":"10.1093\/annonc\/mds173"},{"key":"2865_CR24","doi-asserted-by":"publisher","unstructured":"Nerad E, et al. MRI for local staging of colon cancer: can MRI become the optimal staging modality for patients with colon cancer? Dis Colon Rectum. 2017. https:\/\/doi.org\/10.1097\/dcr.0000000000000794.","DOI":"10.1097\/dcr.0000000000000794"},{"key":"2865_CR25","doi-asserted-by":"publisher","unstructured":"Rollv\u00e9n E, et al. Potentials of high resolution magnetic resonance imaging versus computed tomography for preoperative local staging of colon cancer. Acta Radiol. 2013. https:\/\/doi.org\/10.1177\/0284185113484018.","DOI":"10.1177\/0284185113484018"},{"key":"2865_CR26","doi-asserted-by":"publisher","unstructured":"Stewart C, et al. Assessment of serosal invasion and criteria for the classification of pathological (p) T4 staging in colorectal carcinoma: confusions, controversies and criticisms. Cancers. 2011. https:\/\/doi.org\/10.3390\/cancers3010164.","DOI":"10.3390\/cancers3010164"},{"key":"2865_CR27","doi-asserted-by":"publisher","unstructured":"Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003. https:\/\/doi.org\/10.1097\/01.MP.0000062859.46942.93.","DOI":"10.1097\/01.MP.0000062859.46942.93"},{"key":"2865_CR28","doi-asserted-by":"publisher","unstructured":"Van den Eynden GG, et al. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph) angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology. 2007. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02761.x.","DOI":"10.1111\/j.1365-2559.2007.02761.x"},{"key":"2865_CR29","doi-asserted-by":"publisher","unstructured":"Brabletz T, et al. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005. https:\/\/doi.org\/10.1038\/nrc1694.","DOI":"10.1038\/nrc1694"},{"key":"2865_CR30","doi-asserted-by":"publisher","unstructured":"Micke P, Ostman A. Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy. Expert Opin Ther Targets. 2005. https:\/\/doi.org\/10.1517\/14728222.9.6.1217.","DOI":"10.1517\/14728222.9.6.1217"},{"key":"2865_CR31","doi-asserted-by":"publisher","unstructured":"Puppa G, et al. TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch Pathol Lab Med. 2010. https:\/\/doi.org\/10.1043\/1543-2165-134.6.837.","DOI":"10.1043\/1543-2165-134.6.837"},{"key":"2865_CR32","doi-asserted-by":"publisher","unstructured":"Johnson PM, et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006. https:\/\/doi.org\/10.1200\/JCO.2006.06.8866.","DOI":"10.1200\/JCO.2006.06.8866"},{"key":"2865_CR33","doi-asserted-by":"publisher","unstructured":"Liang WY, et al. Staging of colorectal cancers based on elastic lamina invasion. Hum Pathol. 2019. https:\/\/doi.org\/10.1016\/j.humpath.2018.10.019.","DOI":"10.1016\/j.humpath.2018.10.019"},{"key":"2865_CR34","unstructured":"Knudsen PJ. The peritoneal elastic lamina. J Anat. 1991."},{"key":"2865_CR35","doi-asserted-by":"publisher","unstructured":"Lu J, et al. The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer. PLoS One. 2018. https:\/\/doi.org\/10.1371\/journal.pone.0194804.","DOI":"10.1371\/journal.pone.0194804"},{"key":"2865_CR36","doi-asserted-by":"publisher","unstructured":"Andr\u00e9 T, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol. 2015. https:\/\/doi.org\/10.1200\/jco.2015.63.4238.","DOI":"10.1200\/jco.2015.63.4238"},{"key":"2865_CR37","doi-asserted-by":"publisher","unstructured":"Grothey A, et al. Duration of adjuvant chemotherapy for stage III colon cancer. N Engl J Med. 2018. https:\/\/doi.org\/10.1056\/NEJMoa1713709.","DOI":"10.1056\/NEJMoa1713709"},{"key":"2865_CR38","doi-asserted-by":"publisher","unstructured":"Tie J, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3616.","DOI":"10.1001\/jamaoncol.2019.3616"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02865-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T04:19:56Z","timestamp":1670818796000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02865-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02865-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"8 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was examined and certified by the Ethics Committee of the Cancer Hospital of China Medical University (No. 20170223) and performed according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"391"}}